NIH-funded research NIH-funded research

How serotonin affects brain changes during adolescence and anxiety management

Official title: Serotonin-mediated reorganization of the adolescent medial prefrontal cortex

Funded at University of Toledo Health Sci Campus · NIH-11309214 · Data updated 2026-11-12

This study is looking at how serotonin affects the teenage brain, especially in a part that helps control fear and anxiety, to find new ways to help young people with anxiety who might not feel better with usual treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Toledo Health Sci Campus
NIH-funded
Lab location1 site (Toledo, United States)
Project startJune 1, 2025
Project endMay 31, 2026
Funding year2025
Award (this year)$545,759
NIH project number1R56MH139698-01
Project IDNIH-11309214 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adolescents aged 12-20 who are experiencing anxiety-related disorders.

Less likely to help

Patients outside the adolescent age range or those without anxiety disorders may not benefit from this research.

What this research studies

This research investigates the role of serotonin in the adolescent brain, particularly focusing on how it influences the medial prefrontal cortex, a region involved in managing fear and anxiety. By studying mouse models, the research aims to understand how enhancing serotonin transmission can improve the brain's ability to regulate fear responses. The findings could lead to better treatment strategies for anxiety disorders in adolescents, especially for those who do not respond well to traditional therapies. The approach combines behavioral interventions with insights into brain chemistry to explore new avenues for anxiety management.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for anxiety disorders in adolescents, enhancing their emotional and social development.

How similar studies have gone: Previous research has shown promising results in combining cognitive behavioral therapy with serotonin reuptake inhibitors, indicating potential for success in this area.

Where this research is happening

  • University of Toledo Health Sci Campus
    Toledo, United States
    Active

Researchers

  • Principal investigator: Ninan, Ipe — University of Toledo Health Sci Campus
  • Study coordinator: Ninan, Ipe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.